✦ LIBER ✦

Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir

✍ Scribed by Nae-Yun Heo; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh

Book ID: 116652166
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 408 KB
Volume: 53
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

Entecavir+adefovir versus lamivudine+ade

Entecavir+adefovir versus lamivudine+adefovir or entecavir alone in lamivudine-resistant chronic hepatitis b: 96-week data from the define study

✍ Heo, Jeong; Ahn, Sang Hoon; Kweon, Young-Oh; Kim, Byung-Ho; Chan, Sang Hoon; Hor 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 66 KB

OL-016 Adefovir plus entecavir or plus l

OL-016 Adefovir plus entecavir or plus lamivudine as rescue therapies for chronic hepatitis B patients who develop resistance to entecavir

✍ S. Yang; R.X. Xue; Q. Wang; H.C. Xing; J. Guo; W. Xie; J. Yan; J. Cheng 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Adefovir-based combination therapy with

Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B

✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV þ LAM therapy

Lamivudine plus adefovir vs. entecavir i

Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir

✍ Chang Young Son; Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Efficacy of Entecavir and Adefovir Combi

Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B

✍ Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jae Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 199 KB